UK markets closed

Sartorius Stedim Biotech S.A. (0RG8.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
367.44+27.78 (+8.18%)
At close: 05:45PM GMT
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3N/A
S&P500 52-week change 314.90%
52-week high 3354.90
52-week low 3338.90
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 824.21M
% held by insiders 173.60%
% held by institutions 113.95%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 26:1
Last split date 306 May 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin 15.56%
Operating margin (ttm)11.52%

Management effectiveness

Return on assets (ttm)6.58%
Return on equity (ttm)18.66%

Income statement

Revenue (ttm)2.96B
Revenue per share (ttm)32.11
Quarterly revenue growth (yoy)-24.10%
Gross profit (ttm)1.83B
Net income avi to common (ttm)460.4M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-87.40%

Balance sheet

Total cash (mrq)118.7M
Total cash per share (mrq)1.29
Total debt (mrq)3.79B
Total debt/equity (mrq)144.33%
Current ratio (mrq)1.79
Book value per share (mrq)28.27

Cash flow statement

Operating cash flow (ttm)625.3M
Levered free cash flow (ttm)-22.32M